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The original version of this article [1], published on 6 
February 2018, contains a mistake in the ‘Conclusions’ 
section. The corrected version of the affected sentence is 
given below and the corrected part is marked in bold.
  • It is unclear whether the reduction in Streptococcus 
is particularly beneficial in some ME/CFS patients or 
whether other concurrent microbial shifts are equally 
or more valuable (i.e., increased Bacteroides and/or 
reduced Clostridium).
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